/Companies

Tr1X Bio

2 known investors

Find your way into Tr1X Bio

Sign up to see every warm intro you have to Tr1X Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tr1X Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.

Founders & leadership

D
DavidCo-Founder
MGMaria Grazia Roncarolo
Maria Grazia RoncaroloCo-Founder, President and Head of R&D

Investors · 2

In the news

Frequently asked questions

What does Tr1X Bio do?
Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
Who founded Tr1X Bio?
Tr1X Bio was founded by David, Maria Grazia Roncarolo.
Who are Tr1X Bio's investors?
Tr1X Bio's investors include Neva Sgr., The Column Group.